Significance of intron 6 sequence variations in the TP53 gene in Li-Fraumeni syndrome

被引:8
作者
Varley, JM
McGown, G
Thorncroft, M
Kelsey, AM
Birch, JM
机构
[1] Paterson Inst Canc Res, CRC, Canc Genet Grp, Manchester M20 4BX, Lancs, England
[2] Royal Manchester Childrens Hosp, Dept Histopathol, Manchester M27 1HA, Lancs, England
[3] Royal Manchester Childrens Hosp, CRC PFCRG, Manchester M27 1HA, Lancs, England
关键词
D O I
10.1016/S0165-4608(01)00428-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many polymorphisms have been reported in the TP53 gene. Some of these are within the coding region, and may affect the function of the p53 protein, others are within introns or non-coding regions, and their significance is unclear. Recently, a number of publications have claimed that polymorphisms within intron 6 are responsible for inherited predisposition to childhood malignancies, familial breast cancer, and Li-Fraumeni syndrome (LFS). We find no evidence for intron 6 sequence variants predisposing to LFS in our cohort of families and, furthermore, we show that some of the conclusions of other groups cannot be supported by data from our analysis. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:85 / 87
页数:3
相关论文
共 14 条
[1]   A novel germ line p53 mutation in intron 6 in diverse childhood malignancies [J].
Avigad, S ;
Barel, D ;
Blau, O ;
Malka, A ;
Zoldan, M ;
Mor, C ;
Fogel, M ;
Cohen, IJ ;
Stark, B ;
Goshen, Y ;
Stein, J ;
Zaizov, R .
ONCOGENE, 1997, 14 (13) :1541-1545
[2]   A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family [J].
Barel, D ;
Avigad, S ;
Mor, C ;
Fogel, M ;
Cohen, IJ ;
Zaizov, R .
CANCER GENETICS AND CYTOGENETICS, 1998, 103 (01) :1-6
[3]   Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[4]   LINKAGE STUDIES IN A LI-FRAUMENI FAMILY WITH INCREASED EXPRESSION OF P53 PROTEIN BUT NO GERMLINE MUTATION IN P53 [J].
BIRCH, JM ;
HEIGHWAY, J ;
TEARE, MD ;
KELSEY, AM ;
HARTLEY, AL ;
TRICKER, KJ ;
CROWTHER, D ;
LANE, DP ;
SANTIBANEZKOREF, MF .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1176-1181
[5]  
BIRCH JM, 1994, CANCER RES, V54, P1298
[6]   BSTNI/NCII POLYMORPHISM OF THE HUMAN P53 GENE (TP53) [J].
CHUMAKOV, PM ;
JENKINS, JR .
NUCLEIC ACIDS RESEARCH, 1991, 19 (24) :6969-6969
[7]  
Lehman TA, 2000, CANCER RES, V60, P1062
[8]  
LI FP, 1988, CANCER RES, V48, P5358
[9]   THE MSPI POLYMORPHISM IN INTRON-6 OF P53 (TP53) DETECTED BY DIGESTION OF PCR PRODUCTS [J].
MCDANIEL, T ;
CARBONE, D ;
TAKAHASHI, T ;
CHUMAKOV, P ;
CHANG, EH ;
PIROLLO, KF ;
YIN, J ;
HUANG, Y ;
MELTZER, SJ .
NUCLEIC ACIDS RESEARCH, 1991, 19 (17) :4796-4796
[10]   A novel polymorphism in intron 6 of the human p53 gene: A possible association with cancer predisposition and susceptibility [J].
Peller, S ;
Kopilova, Y ;
Slutzki, S ;
Halevy, A ;
Kvitko, K ;
Rotter, V .
DNA AND CELL BIOLOGY, 1995, 14 (12) :983-990